| Mohammad Ali Khan, | |
|
12531 Quarterhorse Dr, Bowie, MD 20720-4328 | |
| (240) 515-7980 | |
| Not Available |
| Full Name | Mohammad Ali Khan |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 12531 Quarterhorse Dr, Bowie, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609336668 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | D0096384 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Ali Khan, 12531 Quarterhorse Dr, Bowie, MD 20720-4328 Ph: (240) 515-7980 | Mohammad Ali Khan, 12531 Quarterhorse Dr, Bowie, MD 20720-4328 Ph: (240) 515-7980 |
News Archive
Dr. Shinjini Ghosh and colleagues from the Massachusetts Institute of Technology (MIT), United States, have come up with a predictive model that analyzes the spread of COVID-19 infection in India. Their study titled, "Predictive Model with Analysis of the Initial Spread of COVID-19 in India," was released prior to peer review on the preprint server Medrxiv.
A new study by Mount Sinai researchers has for the first time found that patients with more difficult to treat forms of hepatitis C are half as likely to initiate treatment for the disease, when compared to patients with hepatitis C that is easier to treat. Marital status also affected whether patients chose treatment, as did whether or not they had other diseases.
On Oct. 15, Butte radiologist Dr. Jesse A. Cole accepted a $4 million settlement in his lawsuit against St. James Healthcare and its parent corporation, the Sisters of Charity of Leavenworth Health Systems, Inc., a Kansas not-for-profit corporation (not to be confused with the Sisters of Charity of Leavenworth religious community, a separate entity).
The Alzheimer's vaccine known as Affitope AD01 from Affiris has now entered the clinical phase of its development. All relevant regulatory and statutory approvals have been secured and this innovative treatment is now being tested on humans for the first time.
› Verified 1 days ago
Dr. Zhengtong Pei, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4831 Tesla Dr Ste F, Bowie, MD 20715 Phone: 240-737-0080 Fax: 301-464-2783 | |
Matthew Masaji Kirkbride, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4831 Tesla Dr, Suite F, Bowie, MD 20715 Phone: 240-737-0080 Fax: 301-464-2783 | |
Dr. Tu-anh Chu, MD. Pathology Medicare: Accepting Medicare Assignments Practice Location: 4831 Telsa Dr, Suite F, Bowie, MD 20715 Phone: 240-737-0080 Fax: 301-262-7530 | |
Dr. Theresa Nicol, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4801 Telsa Dr, Suite G, Bowie, MD 20715 Phone: 410-987-8001 | |
Dr. Jeffrey H Baybick, MD Pathology Medicare: Medicare Enrolled Practice Location: 4801 Telsa Dr, Suite G, Bowie, MD 20715 Phone: 410-987-8001 |